Warning: The NCBI web site requires JavaScript to function. more...
The molecular mechanism of osteoclastogenesis in rheumatoid arthritis.
Udagawa N, Kotake S, Kamatani N, Takahashi N, Suda T.
Arthritis Res. 2002;4(5):281-9. Epub 2002 Apr 12. Review.
Related citations
The mechanism of osteoclast differentiation from macrophages: possible roles of T lymphocytes in osteoclastogenesis.
Udagawa N.
J Bone Miner Metab. 2003;21(6):337-43. Review.
Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappaB, osteoprotegerin, and receptor activator of nuclear factor kappaB ligand.
Lee CK, Lee EY, Chung SM, Mun SH, Yoo B, Moon HB.
Arthritis Rheum. 2004 Dec;50(12):3831-43.
RANK, RANKL and osteoprotegerin in arthritic bone loss.
Bezerra MC, Carvalho JF, Prokopowitsch AS, Pereira RM.
Braz J Med Biol Res. 2005 Feb;38(2):161-70. Epub 2005 Feb 15. Review.
CD40 ligation of rheumatoid synovial fibroblasts regulates RANKL-mediated osteoclastogenesis: evidence of NF-kappaB-dependent, CD40-mediated bone destruction in rheumatoid arthritis.
Lee HY, Jeon HS, Song EK, Han MK, Park SI, Lee SI, Yun HJ, Kim JR, Kim JS, Lee YC, Kim SI, Kim HR, Choi JY, Kang I, Kim HY, Yoo WH.
Arthritis Rheum. 2006 Jun;54(6):1747-58.
Activated T lymphocytes suppress osteoclastogenesis by diverting early monocyte/macrophage progenitor lineage commitment towards dendritic cell differentiation through down-regulation of receptor activator of nuclear factor-kappaB and c-Fos.
Grcević D, Lukić IK, Kovacić N, Ivcević S, Katavić V, Marusić A.
Clin Exp Immunol. 2006 Oct;146(1):146-58.
The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
Urushibara M, Takayanagi H, Koga T, Kim S, Isobe M, Morishita Y, Nakagawa T, Löeffler M, Kodama T, Kurosawa H, Taniguchi T.
Arthritis Rheum. 2004 Mar;50(3):794-804.
Interleukin (IL) 18 stimulates osteoclast formation through synovial T cells in rheumatoid arthritis: comparison with IL1 beta and tumour necrosis factor alpha.
Dai SM, Nishioka K, Yudoh K.
Ann Rheum Dis. 2004 Nov;63(11):1379-86.
IFN-gamma-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL.
Kotake S, Nanke Y, Mogi M, Kawamoto M, Furuya T, Yago T, Kobashigawa T, Togari A, Kamatani N.
Eur J Immunol. 2005 Nov;35(11):3353-63.
Activated T lymphocytes support osteoclast formation in vitro.
Horwood NJ, Kartsogiannis V, Quinn JM, Romas E, Martin TJ, Gillespie MT.
Biochem Biophys Res Commun. 1999 Nov;265(1):144-50.
Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis.
Wu Y, Liu J, Feng X, Yang P, Xu X, Hsu HC, Mountz JD.
Arthritis Rheum. 2005 Oct;52(10):3257-68.
T-cell leukemia translocation-associated gene (TCTA) protein is required for human osteoclastogenesis.
Kotake S, Nanke Y, Kawamoto M, Yago T, Udagawa N, Ichikawa N, Kobashigawa T, Saito S, Momohara S, Kamatani N, Yamanaka H.
Bone. 2009 Oct;45(4):627-39. Epub 2009 Jun 25.
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance.
Lubberts E, van den Bersselaar L, Oppers-Walgreen B, Schwarzenberger P, Coenen-de Roo CJ, Kolls JK, Joosten LA, van den Berg WB.
J Immunol. 2003 Mar 1;170(5):2655-62.
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells.
Toraldo G, Roggia C, Qian WP, Pacifici R, Weitzmann MN.
Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):125-30. Epub 2002 Dec 18.
The active metabolite of leflunomide, A771726, inhibits both the generation of and the bone-resorbing activity of osteoclasts by acting directly on cells of the osteoclast lineage.
Kobayashi Y, Ueyama S, Arai Y, Yoshida Y, Kaneda T, Sato T, Shin K, Kumegawa M, Hakeda Y.
J Bone Miner Metab. 2004;22(4):318-28.
Inhibition of hormone and cytokine-stimulated osteoclastogenesis and bone resorption by interleukin-4 and interleukin-13 is associated with increased osteoprotegerin and decreased RANKL and RANK in a STAT6-dependent pathway.
Palmqvist P, Lundberg P, Persson E, Johansson A, Lundgren I, Lie A, Conaway HH, Lerner UH.
J Biol Chem. 2006 Feb 3;281(5):2414-29. Epub 2005 Oct 25.
Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts.
Rifas L, Arackal S, Weitzmann MN.
J Cell Biochem. 2003 Mar 1;88(4):650-9.
Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling.
Rahman MM, Bhattacharya A, Fernandes G.
J Lipid Res. 2006 Aug;47(8):1739-48. Epub 2006 May 15.
Inhibition of RANKL-induced osteoclast formation in mouse bone marrow cells by IL-12: involvement of IFN-gamma possibly induced from non-T cell population.
Nagata N, Kitaura H, Yoshida N, Nakayama K.
Bone. 2003 Oct;33(4):721-32.
Bone destruction in arthritis.
Gravallese EM.
Ann Rheum Dis. 2002 Nov;61 Suppl 2:ii84-6. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on